| Title |
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04453-5 |
| Pubmed ID | |
| Authors |
Bastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, Jozefien Declercq, Karel Van Damme, Anja Delporte, Bénédicte Demeyere, Stéfanie Vermeersch, Marnik Vuylsteke, Joren Willaert, Laura Bollé, Yuri Vanbiervliet, Jana Decuypere, Frederick Libeer, Stefaan Vandecasteele, Isabelle Peene, Bart Lambrecht |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Belgium | 2 | 50% |
| United States | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 265 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 265 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 14% |
| Student > Bachelor | 36 | 14% |
| Student > Master | 24 | 9% |
| Other | 18 | 7% |
| Student > Ph. D. Student | 16 | 6% |
| Other | 50 | 19% |
| Unknown | 85 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 34% |
| Nursing and Health Professions | 17 | 6% |
| Biochemistry, Genetics and Molecular Biology | 10 | 4% |
| Agricultural and Biological Sciences | 9 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
| Other | 38 | 14% |
| Unknown | 94 | 35% |